BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 2123104)

  • 1. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145.
    Azam M; Jain S; Baquer NZ
    Biochem Pharmacol; 1990 Nov; 40(10):2215-8. PubMed ID: 2123104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
    Severina IS; Klimova GI; Nersisian AA
    Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl].
    Severina IS
    Biokhimiia; 1983 Sep; 48(9):1513-21. PubMed ID: 6414536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clorgyline and deprenyl insensitive monoamine oxidase in rat brain soluble fraction.
    Shekhar C; Mayanil K; Baquer NZ
    Biochem Pharmacol; 1982 Dec; 31(23):3925-7. PubMed ID: 6818972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications.
    Fowler CJ; Oreland L; Callingham BA
    J Pharm Pharmacol; 1981 Jun; 33(6):341-7. PubMed ID: 6115003
    [No Abstract]   [Full Text] [Related]  

  • 7. Modulation by phospholipids of the activity of monoamine oxidase purified from pig liver.
    Inagaki T; Rao NA; Yagi K
    J Biochem; 1986 Sep; 100(3):597-603. PubMed ID: 3096981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic toxicity in mice by MDL 72145, a selective inhibitor of MAO-B.
    Kindt MV; Heikkila RE
    Life Sci; 1986 Apr; 38(16):1459-62. PubMed ID: 3084895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of type A monoamine oxidase in mouse and rabbit liver mitochondria.
    Suzuki O; Mizutani S; Katsumata Y; Oya M
    Experientia; 1981 Jan; 37(1):18-9. PubMed ID: 6781927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of monoamine oxidase in monkey heart.
    Katayama M; Kobayashi S; Oguchi K; Yasuhara H
    Jpn J Pharmacol; 1984 Aug; 35(4):425-31. PubMed ID: 6438377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of monoamine oxidase type B by MDL 72145 increases the central effects of L-dopa without modifying its cardiovascular effects.
    Fozard JR; Palfreyman MG; Robin M; Zreika M
    Br J Pharmacol; 1986 Jan; 87(1):257-64. PubMed ID: 3082400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The functional consequences of inhibition of monoamine oxidase type B: comparison of the pharmacological properties of L-deprenyl and MDL 72145.
    Fozard JR; Zreika M; Robin M; Palfreyman MG
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):186-93. PubMed ID: 3937059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of the active site of brain monoamine oxidase.
    Youdim MB
    Monogr Neural Sci; 1980; 7():176-92. PubMed ID: 6785574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate selectivity of type A and type B monoamine oxidase in rat brain.
    Kinemuchi H; Wakui Y; Kamijo K
    J Neurochem; 1980 Jul; 35(1):109-15. PubMed ID: 6778959
    [No Abstract]   [Full Text] [Related]  

  • 15. The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline.
    Fowler CJ; Mantle TJ; Tipton KF
    Biochem Pharmacol; 1982 Nov; 31(22):3555-61. PubMed ID: 6817759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
    Cabanillas AM; Masini-Repiso AM; Costamagna ME; Pellizas C; Coleoni AH
    J Endocrinol; 1994 Nov; 143(2):303-8. PubMed ID: 7829993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and properties of mitochondrial monoamine oxidase type A from human placenta.
    Weyler W; Salach JI
    J Biol Chem; 1985 Oct; 260(24):13199-207. PubMed ID: 3932340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate specificity and inhibitor sensitivity of monoamine oxidase in rat kidney mitochondria.
    Lyles GA; Shaffer CJ
    Biochem Pharmacol; 1979 Apr; 28(7):1099-106. PubMed ID: 444267
    [No Abstract]   [Full Text] [Related]  

  • 19. Alteration of dopamine synthesis in rat striatum subsequent to selective type A monoamine oxidase inhibition.
    Schoepp DD; Azzaro AJ
    J Neurochem; 1981 Aug; 37(2):527-30. PubMed ID: 6790675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reaction of bovine and rat liver monoamine oxidase with [14C]-clorgyline and [14C]-deprenyl.
    Salach JI; Detmer K; Youdim MB
    Mol Pharmacol; 1979 Jul; 16(1):234-41. PubMed ID: 481419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.